Phasex

Phasex Corporation specializes in the application of supercritical fluid technology to solve complex processing challenges in the pharmaceutical and medical products industries. Supercritical fluids, which possess unique properties such as pressure-tunable dissolving power and gas-like transport capabilities, are used to extract, purify, and recrystallize fine chemicals and pharmaceuticals. This technology offers an alternative to traditional processing methods, enabling the development of new product forms and improving existing ones. Phasex conducts short, fast-response feasibility studies to demonstrate the technical and economic viability of using supercritical fluids, catering to R&D companies that are cautious about outsourcing innovation. The company operates in the pharmaceutical sector, serving clients who require advanced processing solutions to enhance product development and efficiency. Phasex's business model revolves around providing specialized R&D services and consulting, generating revenue through project-based engagements.

Keywords: supercritical fluids, pharmaceutical processing, extraction, purification, recrystallization, feasibility studies, R&D services, innovation, product development, medical products.